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I N T R O D U C T I O N
In skeletal muscle, the L-type Ca
2+ channel (or 1,4-dihydro-
pyridine receptor [DHPR]) serves as the voltage sensor 
(Schneider and Chandler, 1973; Ríos and Brum, 1987; 
Tanabe et al., 1988) for excitation–contraction coupling 
(ECC) by triggering the opening of the type 1 ryanodine-
sensitive SR Ca
2+ release channel (RYR1) in the SR. This 
“orthograde” signal appears to be mediated by con-
formational coupling between the DHPR and RYR1 
because ECC is rapid, persists in the absence of extra-
cellular  Ca
2+  (Armstrong  et  al.,  1972;  Tanabe  et  al., 
1990), and can be restored in dysgenic (DHPR 1S sub-
unit  null)  myotubes  by  expression  of  an  1S  subunit 
(SkEIIIK) with a very low Ca
2+ permeability (Dirksen 
and Beam, 1999; Bannister et al., 2009b). In addition to 
the orthograde ECC signal from the DHPR to RYR1, 
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there is also a retrograde signal whereby RYR1 increases 
the magnitude of the L-type Ca
2+ current generated by 
the  DHPR,  most  likely  as  a  consequence  of  increased 
channel Po (Nakai et al., 1996). This retrograde effect of 
RYR1 is independent of SR Ca
2+ release (Grabner et al., 
1999; Hurne et al., 2005) and affects not only the magni-
tude of the current, but also activation kinetics (Avila and 
Dirksen, 2000; Ahern et al., 2003; Sheridan et al., 2006).
The existence of physical links between DHPRs and 
RYR1 is strongly supported by freeze-fracture analyses 
that reveal that intramembranous particles, which are 
likely to be DHPRs in the plasma membrane at sites   
of junction with the SR, are arranged into “tetrads” with 
a spacing that places them in register with the four 
subunits  of  every  other  RYR1  (Block  et  al.,  1988; 
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Bidirectional communication between the 1,4-dihydropyridine receptor (DHPR) in the plasma membrane 
and the type 1 ryanodine receptor (RYR1) in the sarcoplasmic reticulum (SR) is responsible for both skeletal-type 
excitation–contraction coupling (voltage-gated Ca
2+ release from the SR) and increased amplitude of L-type Ca
2+ 
current via the DHPR. Because the DHPR and RYR1 are functionally coupled, mutations in RYR1 that are linked 
to malignant hyperthermia (MH) may affect DHPR activity. For this reason, we investigated whether cultured myo-
tubes originating from mice carrying an MH-linked mutation in RYR1 (R163C) had altered voltage-gated Ca
2+  
release from the SR, membrane-bound charge movement, and/or L-type Ca
2+ current. In myotubes homozygous 
(Hom) for the R163C mutation, voltage-gated Ca
2+ release from the SR was substantially reduced and shifted (10 mV) 
to more hyperpolarizing potentials compared with wild-type (WT) myotubes. Intramembrane charge movements 
of both Hom and heterozygous (Het) myotubes displayed hyperpolarizing shifts similar to that observed in voltage-
gated SR Ca
2+ release. The current–voltage relationships for L-type currents in both Hom and Het myotubes were 
also shifted to more hyperpolarizing potentials (7 and 5 mV, respectively). Compared with WT myotubes, Het 
and Hom myotubes both displayed a greater sensitivity to the L-type channel agonist ±Bay K 8644 (10 µM). In general, 
L-type currents in WT, Het, and Hom myotubes inactivated modestly after 30-s prepulses to 50, 10, 0, 10, 20, 
and 30 mV. However, L-type currents in Hom myotubes displayed a hyperpolarizing shift in inactivation relative to 
L-type currents in either WT or Het myotubes. Our present results indicate that mutations in RYR1 can alter DHPR 
activity and raise the possibility that this altered DHPR function may contribute to MH episodes.
© 2010 Bannister et al.  This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi-
cation date (see http://www.rupress.org/terms). After six months it is available under a 
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, 
as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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baseline during the test pulse, and F is the fluorescence immedi-
ately before the test pulse minus the average background (non–
Fluo-3) fluorescence. The peak value of the fluorescence change 
(F/F) for each test potential (V) was fitted according to:
  ∆ ∆ F F    F F 1 exp V V k max F F / [ / ] / / , = + − − ( ) { }        (1)
where [F/F]max is the maximal fluorescence change, VF is the 
potential causing half the maximal change in fluorescence, and 
kF is a slope parameter.
Electrophysiology
Pipettes were fabricated from borosilicate glass and had resistances 
of 1.5 MΩ when filled with internal solution, which consisted of 
(in mM): 140 Cs-aspartate, 10 Cs2-EGTA, 5 MgCl2, and 10 HEPES, 
pH 7.4 with CsOH. The external solution contained (in mM):   
145 tetraethylammonium-Cl, 10 CaCl2, 0.003 tetrodotoxin, and 
10 HEPES, pH 7.4 with tetraethylammonium-OH. In some experi-
ments, myotubes were exposed to racemic Bay K 8644 (provided 
by A. Scriabine, Miles Laboratories Inc., New Haven, CT) in the bath 
solution. Racemic Bay K 8644 was stored as a 20-mM stock in 50% 
EtOH and was diluted in the external recording solution just 
before experiments.
For measurement of charge movements, ionic currents were 
blocked by the addition of 0.5 mM CdCl2 plus 0.1 mM LaCl3 to 
the extracellular recording solution. All charge movements were 
corrected for linear cell capacitance and leakage currents using 
a P/8 subtraction protocol (Bannister et al., 2008a,b, 2009a). Filter-
ing was at 2 kHz (eight-pole Bessel filter; Frequency Devices, Inc.), 
and digitization was at 20 kHz. Voltage clamp command pulses 
were exponentially rounded with a time constant of 50–500 µs, 
and a 1-s prepulse to 20 mV, followed by a 50-ms repolarization 
to 50 mV, was administered before the test pulse (prepulse proto-
col; see Adams et al., 1990) to reduce the contribution of gating 
currents from voltage-gated Na
+ channels and low voltage–activated 
Ca
2+ channels. The integral of the ON transient (Qon) for each 
test potential (V) was fitted according to:
  Q  Q 1 exp V V k on max Q Q = + − − ( ) 


 { } / / ,   (2)
where Qmax is the maximal Qon, VQ is the potential causing move-
ment of half the maximal charge, and kQ is a slope parameter.
For generation of I-V relationships, linear capacitative and 
leakage  currents  were  determined  by  averaging  the  currents 
elicited by 11 30-mV hyperpolarizing pulses from the holding 
potential of 80 mV. Test currents were corrected for linear 
components of leak and capacitive current by digital scaling and 
subtraction of this average control current. In all other experi-
ments,  P/4  subtraction  was  used.  Electronic  compensation 
was used to reduce the effective series resistance (usually to   
<1 MΩ) and the time constant for charging the linear cell capac-
itance (usually to <0.5 ms). L-type currents were filtered at 2 kHz 
and digitized at 5–10 kHz. In most cases, the prepulse protocol 
(see  above)  was  used  to  inactivate  low  voltage–activated  Ca
2+ 
channels. Cell capacitance was determined by integration of a 
transient evoked by stepping from 80 to 70 mV using Clam-
pex 8.0 (MDS Analytical Technologies) and was used to normalize 
current amplitudes (pA/pF). I-V curves were fitted using the fol-
lowing equation:
      ^ ` ª º       ¬ ¼ max rev 1/2 G I   G *  V   V / 1   exp V   V /k ,   (3)
where I is the peak current for the test potential V, Vrev is the re-
versal potential, Gmax is the maximum Ca
2+ channel conductance, 
V1/2 is the half-maximal activation potential, and kG is the slope 
Takekura et al., 1994, 2004; Protasi et al., 2002; Sheridan 
et al., 2006). Moreover, a conformational change of 
RYR1 that is induced by exposure to high ryanodine 
causes a 2-nm decrease in distance between adjacent   
tetradic particles, further supporting the hypothesis   
that DHPRs are docked to RYR1 (Paolini et al., 2004). 
Treatment with ryanodine similar to that causing rear-
rangement of tetradic particles also alters DHPR gating 
(Bannister and Beam, 2009). Thus, the retrograde signal 
appears to depend upon the conformation of RYR1.
Given the evidence that RYR1 has retrograde effects 
on DHPR function, and that this retrograde signal is   
affected by RYR1 conformation as described above, the 
question naturally arises of whether malignant hyper-
thermia (MH)-causing mutations in RYR1 affect DHPR 
function. Recently, alterations in the function of the 
DHPR as ECC voltage sensor and as an L-type Ca
2+ chan-
nel have been reported in muscle cells harvested from 
mice carrying the MH-linked Y522S mutation of RYR1 
(Chelu et al., 2006; Durham et al., 2008; Andronache   
et al., 2009). In the present study, we have used whole cell 
patch clamping to assess directly the effects of another 
MH-linked mutation in RYR1 (R163C) on currents gen-
erated by DHPR. We found that the R163C mutation   
alters multiple aspects of the function of the DHPR   
as both ECC voltage sensor and as L-type Ca
2+ channel, 
raising the possibility that altered DHPR activity may con-
tribute to the pathophysiology associated with at least 
some of the MH-causing mutations of RYR1.
M AT E R I A L S   A N D   M E T H O D S
Myotube culture
The University of Colorado-Anschutz Medical Campus and Har-
vard Medical School Institutional Animal Care and Use Commit-
tees approved all procedures involving mice. Myoblast cell lines 
were generated from the limb muscles of neonatal heterozygous 
(Het) and homozygous (Hom) F2 MHR163C C57Bl6/129svJ mice 
and their wild-type (WT) littermates (Rando and Blau, 1994; Yang 
et al., 2006). Myoblasts were differentiated into myotubes by with-
drawal of growth factors, as described previously (Yang et al., 2003), 
and used in electrophysiological experiments 5–7 d later.
Measurement of intracellular Ca
2+ transients
All experiments were performed at room temperature (25°C). 
Changes in intracellular Ca
2+ were recorded with Fluo-3 (Invitro-
gen) in the whole cell patch clamp configuration (see below). The 
salt form of the dye was added to the standard internal solution 
(see below) for a final concentration of 200 µM. After entry into 
the whole cell configuration, a waiting period of >5 min was used to 
allow the dye to diffuse into the cell interior. A 100-W mercury illu-
minator and a set of fluorescein filters were used to excite the dye 
present in a small rectangular region of the voltage-clamped myo-
tube. A computer-driven shutter was used to block illumination in 
the intervals between 50-ms test pulses. Fluorescence emission was 
measured by means of a fluorometer apparatus (Biomedical Instru-
mentation Group, University of Pennsylvania, Philadelphia, PA). 
The average background fluorescence was quantified before bath 
immersion of the patch pipette. Fluorescence data are expressed as 
F/F, where F represents the change in peak fluorescence from   Bannister et al. 631
R E S U LT S
SR Ca
2+ release is shifted to more hyperpolarized 
potentials in R163C myotubes
Because the R163C mutation was shown to cause Ca
2+ 
to be released from the SR in response to smaller ele-
vations of extracellular K
+ applied to intact myotubes 
(Yang et al., 2006; Estève et al., 2010), we sought to de-
termine whether a corresponding effect occurred in 
myotubes subjected to whole cell patch clamp. To as-
sess directly the effects of the R163C mutation on voltage-
triggered  Ca
2+  release,  without  complications  from 
RYR1 tetramers having variable WT/mutant monomer 
stoichiometry, we initially compared Ca
2+ transients of 
myotubes Hom for the R163C mutation with those of 
WT myotubes. As shown in Fig. 1 A, WT myotubes pro-
duced robust Ca
2+ transients with an average [F/F]max 
of 0.76 ± 0.15 (n = 11). In contrast, R163C Hom myo-
tubes yielded Ca
2+ transients that were considerably 
smaller in magnitude ([F/F]max = 0.29 ± 0.09; n = 6;   
P < 0.05; Fig. 1 B). Such a reduction in the magnitude   
of SR Ca
2+ release was most likely related to reduc-
tions in DHPR expression (see below). The reduction in 
[F/F]max observed for Hom myotubes was accompa-
nied by a substantial (10 mV; P < 0.05) hyperpolariz-
ing  shift  in  the  voltage  dependence  of  Ca
2+  release 
factor. The activation phase of L-type currents was fitted using the 
following exponential function:
  I t    A exp t    A exp t    C fast fast slow slow ( ) = − + − [ ] + [ ( / )] ( / ) , τ τ   (4)
where I(t) is the current at time t after the depolarization, Afast and 
Aslow are the steady-state current amplitudes of each component with 
their respective time constants of activation (fast and slow), and C 
represents the steady-state current (see Avila and Dirksen, 2000).
In steady-state inactivation experiments, cells were held at pre-
pulse potentials (50, 10, 0, 10, 20, and 30 mV) for 30 s before 
a 200-ms test depolarization to +30 mV. To minimize the cumula-
tive effects of holding at less negative potentials, an interval of   
>1 min at the steady holding potential (80 mV) was maintained 
between each test pulse and the subsequent prepulse (see Beam 
and Knudson, 1988). Steady-state inactivation curves were fit by 
the Boltzmann equation:
  I I  1 1 1    exp V   V inact k o 1 2 / / / , / = − + − − ( )     { }    (5)
where I is the current amplitude for a test depolarization to +30 mV 
immediately after a 30-s prepulse V, Io is the current amplitude of 
a reference pulse from 80 to +30 mV evoked just before each 
prepulse, V1/2inact is the half-maximal inactivation potential, and   
k is the slope factor.
Analysis
Figures were made using the software program SigmaPlot (ver-
sion 11.0; SPSS Inc.). All data are presented as mean ± SEM. Sta-
tistical comparisons were by ANOVA or unpaired, two-tailed t test 
(as appropriate), with P < 0.05 considered significant.
Figure 1.  SR Ca
2+ release is shifted to more hyperpolarized potentials in R163C MHS myotubes. Representative myoplasmic Ca
2+ tran-
sients elicited by 50-ms depolarizations from 50 mV to test potentials of 30, 10, 10, and 30 mV are shown for WT (A), Hom (B), 
and Het (C) myotubes. Raw F/F-V relationships are shown in D. The average F/F-V relationships, obtained after normalizing to the 
[F/F]max in each individual experiment, are shown in E, with the smooth curves plotted according to Eq. 1 and best-fit parameters 
presented in Table I. Error bars represent ± SEM.632 RYR1 influences DHPR function
The R163C mutation causes a small hyperpolarizing shift  
in the activation of L-type current
We next examined whether the R163C mutation also 
caused changes in L-type currents generated by the 
DHPR. Representative L-type currents recorded from 
WT, Het, and Hom myotubes are illustrated in Fig. 3 A. 
The L-type currents in Het and Hom myotubes differed in 
two small respects from those in WT myotubes. First, 
as shown in Fig. 3 B, peak current amplitudes in Het 
(9.9 ± 0.7 pA/pF at +30 mV; n = 22) and Hom (9.4 ± 
0.6 pA/pF at +30 mV; n = 28) myotubes were reduced   
(P < 0.05, ANOVA) compared with WT myotubes (12.6 ±   
1.1 pA/pF at +40 mV; n = 25). These reductions in 
maximal current density for Het and Hom myotubes 
were proportional to the respective reductions in Qmax 
(see Fig. 2 D), as indicated by the nearly identical 
Gmax/Qmax ratios (Table II). Second, comparison of the 
(Fig. 1 D and Table I). This shift was more evident 
when the respective F/F-V curves were normalized 
to the peak F/F in each experiment (Fig. 4 E). Con-
sistent with previous studies in intact myotubes (Yang 
et al., 2006; Cherednichenko et al., 2008), the voltage 
dependence of myoplasmic Ca
2+ release for Het myo-
tubes (V1/2F = 3.8 ± 4.3 mV; n = 7) was intermedi-
ate between those of WT and Hom myotubes (Fig. 1, 
C–E, and Table I).
The R163C mutation reduces DHPR expression and alters 
the voltage dependence of charge movement
We  recorded  membrane-bound  charge  movements   
to investigate the possibility that the hyperpolarizing 
shifts  in  the  F/F-V  relationships  for  R163C  MH- 
susceptible (MHS) myotubes were related to similar 
hyperpolarizing shifts in charge movement. Substan-
tial charge movements were present in the myotubes 
of all three genotypes (Fig. 2, A–C). The magnitude 
of the charge movements was reduced in both Het 
and Hom myotubes (Qmax = 7.4 ± 1.0 nC/µF; n = 7, 
and 6.4 ± 0.7 nC/µF; n = 7, respectively) compared 
with WT myotubes (9.9 ± 1.1 nC/µF; n = 7), although 
this reduction was significant only for Hom (P < 0.05 
by t test; Table II). The reductions in maximal charge 
movement indicate decreases in the number of func-
tional  DHPRs  in  the  plasma  membranes  of  both 
R163C  Het  and  Hom  myotubes.  The  Q-V  relation-
ships were shifted 10 mV in the hyperpolarizing di-
rection for both Het and Hom myotubes (V1/2 = 9.9 ±   
2.9 and 13.7 ± 2.3 mV, respectively) relative to WT 
myotubes (1.8 ± 2.9 mV; P < 0.005, ANOVA; Fig. 2 D 
and Table II).
TA B L E   I
F/F-V fit parameters
Genotype F/F-V
[F/F]max VF kF
mV mV
WT 0.76 ± 0.15 
(11)
1.5 ± 2.3 4.4 ± 0.4
Het 0.56 ± 0.13 
(7)
3.8 ± 4.3 4.8 ± 0.6
Hom 0.29 ± 0.09
a 
(6)
7.7 ± 3.5
a 6.2 ± 0.9
a
Average values of parameters obtained by fits of Eq. 1 to F/F-V data (see 
Materials and methods). Data are given as mean ± SEM, with the numbers 
in parentheses indicating the number of myotubes tested.
aSignificant differences from WT myotubes (P < 0.05, t test).
Figure  2.  Charge  movements 
are shifted to more hyperpolar-
ized  potentials  in  R163C  Het 
and  Hom  myotubes.  Represen-
tative  charge  movements  elic-
ited  by  20-ms  depolarizations 
from 50 mV to test potentials 
of 30, 10, 10, and 30 mV are 
shown for WT (A), Het (B), and 
Hom  (C)  myotubes.  Raw  Q-V   
relationships  are  shown  in  D. 
The average Q-V relationships, 
obtained after normalizing to the 
Qmax  in  each  individual  experi-
ment, are shown in E, with the 
smooth curves plotted according 
to Eq. 2 and best-fit parameters 
presented in Table II.  Bannister et al. 633
and/or  reduced  current  densities  observed  in  the 
R163C MHS myotubes.
L-type currents of R163C myotubes are more sensitive  
to ±Bay K 8644
Williams et al. (1991) showed that Bay K 8644 lowers 
the threshold for halothane-induced contractures in 
MHS swine muscle fibers. Because the DHPR is the 
molecular target for Bay K 8644, we tested directly how 
this  agonist  affected  L-type  currents  in  R163C  Het 
and Hom myotubes. As shown previously (Adams and 
Beam, 1989), L-type currents of WT myotubes were only 
weakly potentiated by ±Bay K 8644 (Fig. 4 A). In con-
trast, the potentiation of L-type currents by ±Bay K 8644 
(10 µM) was appreciable in Het myotubes (Fig. 4 B), 
peak I-V relationships of each genotype revealed small 
hyperpolarizing shifts in activation of both Het and 
Hom L-type currents (V1/2 = 19.7 ± 1.2 and 17.9 ± 1.1 
mV, respectively) relative to WT myotubes (V1/2 = 24.8 ± 
1.2 mV; P < 0.001, ANOVA; Table II). These shifts 
were more clearly evident when the I-V data were nor-
malized to the maximum current in each individual 
experiment (Fig. 3 C).
L-type  current  activation  kinetics  appeared  slightly 
faster in Het and Hom myotubes than in WT myotubes 
(when compared at +40 mV; Table III), owing to a re-
duction in the contribution of the slow component of 
activation to the total current amplitude (P < 0.05, 
ANOVA). However, these subtle changes in activation 
may have been related to the shifted I-V relationships 
TA B L E   I I
Charge movement and conductance fit parameters
Genotype/treatment Q-V I-V G/Q
Qmax VQ kQ Gmax V1/2 kG Gmax/Qmax
nC/µF mV mV nS/nF mV mV nS/pC
WT 9.9 ± 1.1 
(7)
1.8 ± 2.9 8.9 ± 0.6 300 ± 18 
(25)
24.8 ± 1.2 6.0 ± 0.2 30
WT + Bay K 8644 ND 256 ± 16 
(9)
15.4 ± 1.7
a 5.6 ± 0.4 ND
Het 7.4 ± 1.0 
(7)
9.9 ± 2.9
b 10.2 ± 1.3 229 ± 14
c 
(22)
19.7 ± 1.2
c 5.9 ± 0.2 31
Het + Bay K 8644 ND 254 ± 28 
(6)
11.7 ± 1.4
a 6.0 ± 0.2 ND
Hom 6.4 ± 0.7
b 
(7)
13.7 ± 2.3
a 8.8 ± 1.1 208 ± 10
a 
(28)
17.9 ± 1.1
a 6.0 ± 0.3 32
Hom + Bay K 8644 ND 254 ± 28 
(9)
11.2 ± 1.3
a 6.4 ± 0.3 ND
Average values of parameters obtained by fits of Eqs. 2 and 3 to Q-V and I-V data, respectively (see Materials and methods). Where indicated, myotubes 
were exposed to 10 µM ±Bay K 8644 for >10 min before experiments. Data are given as mean ± SEM, with the numbers in parentheses indicating the 
number of myotubes tested. ND, not determined.
aSignificant differences compared to L-type currents or charge movements recorded from untreated WT myotubes; P < 0.001, t test.
bP < 0.05, t test.
cP < 0.005, t test.
TA B L E   I I I
Activation fit parameters
Genotype Islow Ifast
slow Aslow Fraction 
(%)
fast Afast Fraction 
(%)
ms pA/pF ms pA/pF
WT 90.7 ± 6.6 
(15)
11.6 ± 1.1
a 79 ± 3
b 9.1 ± 1.7 2.9 ± 0.4 21 ± 3
b
HET 77.9 ± 7.7 
(12)
6.5 ± 1.2 69 ± 4 10.1 ± 1.9 2.5 ± 0.3 31 ± 4
HOM 79.4 ± 8.9 
(14)
5.9 ± 0.6 61± 4 7.7 ± 0.9 3.7 ± 0.4 39 ± 4
The activation phases of L-type currents evoked by test depolarizations from -50 mV to + 40 mV were fitted using Eq. 4 (see Materials and methods). Data 
are given as mean ± SEM, with the numbers in parentheses indicating the number of myotubes tested. The analysis of activation kinetics excluded cells in 
which tail current decay was obviously not monoexponential.
aSignificant differences among the three genotypes (P < 0.001, ANOVA).
bP < 0.005, ANOVA.634 RYR1 influences DHPR function
removal of inactivation during the intervals at 80 mV. 
Thus, steady-state inactivation was measured as the 
fraction of the L-type current amplitude evoked by de-
polarization to +30 mV immediately after the 30-s pre-
pulse divided by the L-type current amplitude evoked 
by a “control” depolarization to +30 mV from the 80-mV 
holding potential just before each prepulse. As shown 
in Fig. 5 B, L-type currents in WT, Het, and Hom myo-
tubes only displayed relatively modest inactivation. Fit-
ting of the normalized inactivation–voltage relationship 
for  WT  and  Het  myotubes  yielded  nearly  equivalent 
half-inactivation potentials (V1/2inact = 6.1 and 5.3 mV, 
respectively;  Fig.  5  C).  The  inactivation–voltage  rela-
tionship for Hom myotubes (V1/2inact = 3.3 mV) was 
shifted to more hyperpolarized potentials (Fig. 5 C).
D I S C U S S I O N
In this study, we have used patch clamp electrophysiol-
ogy to investigate effects of the MHS mutation R163C   
in RYR1. In particular, the function of the DHPR as   
voltage sensor for ECC was modified such that the 
dependence of SR Ca
2+ release on membrane potential 
and even larger in Hom myotubes (Fig. 4 C). To quan-
tify  these  differential  effects,  a  potentiation  index 
[(IBay K 8644Icontrol)/Icontrol] was calculated from the av-
erage peak current at +30 mV for each genotype; the 
values for WT, Het, and Hom cells were 0.21, 0.39, 
and 0.71, respectively.
DHPR steady-state inactivation is shifted to hyperpolarized 
potentials in R163C Hom myotubes
A recent study reported that the RYR1 Y522S MHS mu-
tation altered the voltage dependence of L-type current 
inactivation (Andronache et al., 2009). To determine 
whether the R163C mutation has a similar influence   
on inactivation of L-type current, we used the voltage 
protocol illustrated in Fig. 5 A. Specifically, 30-s pre-
pulses to varying potentials (50, 10, 0, 10, 20, and   
30 mV) were applied before a 200-ms test depolarization 
to +30 mV. Importantly, an interval of >1 min at 80 mV 
was used between each test pulse and the subsequent 
prepulse to minimize the cumulative effects of holding 
at less negative potentials. Even with this protocol, there 
was an ongoing decline of the L-type current over time 
(unpublished data), presumably due to incomplete 
Figure 3.  L-type currents in R163C Het and 
Hom  myotubes  are  shifted  to  slightly  more 
hyperpolarized  potentials.  (A)  Representa-
tive recordings of L-type Ca
2+ currents elicited 
by 200-ms depolarizations from 50 mV to 
test potentials of 0, 10, 20, 30, and 40 mV are 
shown for WT (top), Het (middle), and Hom 
(bottom) myotubes. (B) Comparison of peak 
I-V relationships for WT (n = 25), Het (n = 22), 
and Hom (n = 28) cells. Currents were evoked 
at 0.1 Hz by test potentials ranging from 20 
through +80 mV in 10-mV increments, follow-
ing a prepulse protocol (Adams et al., 1990). 
Current amplitudes were normalized by lin-
ear cell capacitance (pA/pF). (C) I-V rela-
tionships for the same dataset shown in B, in 
which the current amplitudes have been nor-
malized to the peak current in each cell. The 
smooth curves are plotted according to Eq. 3, 
with best-fit parameters presented in Table II.  Bannister et al. 635
In R163C Het myotubes, there was a small hyperpolariz-
ing shift in SR Ca
2+ release and a slight reduction in maxi-
mal release ([F/F]max) relative to WT myotubes (Fig. 1 
and Table I). In R163C Hom myotubes, the voltage depen-
dence of SR Ca
2+ release shifted to a greater extent and 
maximal release was substantially reduced (Fig. 1 and   
Table I). As for Hom R163C myotubes, hyperpolarizing 
shifts in the voltage dependence of Ca
2+ release have also 
been reported for myotubes harvested from Y522S Hom 
mice (Chelu et al., 2006) or R615C Hom swine (Dietze   
et al., 2000), and for dyspedic myotubes expressing RYR1 
constructs carrying several different MH mutations (Avila 
and Dirksen, 2001; Dirksen and Avila, 2004; Lyfenko et al., 
2004). A reduction in maximal release, like that we ob-
served in R163C Hom myotubes, was previously reported 
for Y522S Hom myotubes (Chelu et al., 2006). For R163C 
Hom myotubes, a reduced number of DHPRs (Fig. 2) is 
probably one contributor to the reduction in [F/F]max. 
was shifted in the hyperpolarizing direction in myotubes 
either Hom or Het for the R163C mutation (Fig. 1 and 
Table I). Hom and Het myotubes displayed hyperpolar-
izing shifts in the voltage dependence of the membrane-
bound  charge  movement  (Fig.  2  and  Table  II)  that 
roughly paralleled the shifts in SR Ca
2+ release. Although 
smaller than the shift in charge movement, the activation 
of L-type currents in Hom and Het myotubes was also 
shifted in the hyperpolarizing direction (Fig. 3). A more 
striking effect of the R163C mutation on L-type channel 
gating was that the dihydropyridine agonist ±Bay K 8644 
caused a larger potentiation of L-type current in Het and 
Hom myotubes than in WT myotubes (Fig. 4). For all 
three genotypes, inactivation of L-type currents by 30-s 
prepulses occurred at relatively depolarized potentials;   
L-type currents in Hom myotubes inactivated at 10 mV 
more hyperpolarized potentials than L-type current of 
either WT or Het myotubes (Fig. 5).
Figure  4.  L-type  currents  in  R163C  Het   
and  Hom  myotubes  are  more  sensitive  to   
±Bay  K  8644.  Representative  recordings  of   
L-type  currents  made  in  the  presence  of 
±Bay K 8644 are shown for WT (A; left), Het 
(B; left), and Hom (C; left) myotubes. Cur-
rents were elicited by 200-ms depolarizations 
from 50 mV to test potentials of 0, 10, 20, 
and  30  mV.  The  average  peak  I-V  relation-
ships obtained in the absence (circles) and 
presence (diamonds) of 10 µM ±Bay K 8644 
and  are  shown  in  A  (right)  for  WT  myo-
tubes (, n = 9; , n = 25), in B (right) for 
Het  myotubes  (,  n  =  6;  ,  n  =  22),  and 
in  C  (right)  for  Hom  myotubes  (,  n  =  9;   
,  n  =  28).  Peak  I-V  data  obtained  in  the   
absence of ±Bay K 8644 are replotted from 
Fig.  3,  and  the  smooth  curves  are  plotted 
according to Eq. 3, with best-fit parameters 
given in Table II.636 RYR1 influences DHPR function
did not observe a shift in charge movement. Recently, 
however, Andronache et al. (2009) reported a hyper-
polarizing  shift  of  5  mV  in  charge  movements  of 
Y522S Het fibers.
Hyperpolarizing shifts in the activation of L-type cur-
rent have been consistently observed in animal models 
of MH. In this study, we observed hyperpolarizing shifts 
in L-type current activation for both R163C Het and 
Hom (5 and 7 mV, respectively). Earlier, Gallant et al. 
(1996) saw a small hyperpolarizing shift in R615C Hom 
swine myotubes but suggested that series resistance er-
rors could have contributed to the effect. More recently, 
Interestingly, Lamb et al. (1989) also found a reduction in 
Qmax (20%) in swine R615C Hom gracilis fibers. More-
over, Andronache et al. (2009) found an 10% reduction 
in Qmax in Y522S Het interosseus fibers.
Corresponding  to  the  respective  9-  and  5-mV   
hyperpolarizing  shifts  in  the  voltage  dependence  of 
Ca
2+ release for R163C Hom and Het myotubes (Table I), 
we also observed an 16-mV hyperpolarizing shift in 
charge movements in Hom myotubes and a somewhat 
smaller shift (12 mV) in Het myotubes (Fig. 2 and 
Table II). In an earlier study describing charge move-
ments in swine R615C Hom fibers, Lamb et al. (1989) 
Figure 5.  Steady-state inactivation of L-type 
current  in  WT  and  R163C  MHS  myotubes. 
(A) Voltage protocol. A 200-ms depolarization 
to +30 mV was applied just before (reference 
pulse) and immediately (test pulse) after 30-s 
prepulses to 50, 10, 0, 10, 20, and 30 mV. 
An interval of >1 min at the steady holding 
potential of 80 mV was used between each 
episode  of  the  protocol.  (B)  Test  currents 
elicited with this protocol for the indicated 
prepulse potentials (black traces) are shown 
for  each  genotype,  with  the  corresponding 
control current (gray traces) evoked before 
the pulse run from 80 to +30 mV. The am-
plitudes of the currents shown in B have been 
normalized to the amplitude of the current 
elicited by the reference pulse. (C) Summary 
of results for WT (n = 12–19), Het (n = 6–12), 
and Hom (n = 8–23) myotubes at the indicated 
prepulse  potentials.  The  average  normal-
ized inactivation values were fit by Eq. 5 (see   
Materials  and  methods),  with  the  following 
respective parameters for WT, Het, and Hom 
myotubes: V1/2inact = 6.1, 5.3, and 3.3 mV;   
k = 6.8, 4.3, and 6.6 mV.  Bannister et al. 637
Collectively, the results with whole cell voltage clamp 
measurements in this paper, and the results on myoplas-
mic Ca
2+ transients evoked by application of elevated K
+ 
to intact myotubes, which are described by Estève et al. 
in this issue, indicate that the R163C mutation in RYR1 
alters the gating of the DHPR with respect both to mem-
brane currents and ECC. Moreover, the results obtained 
with the two approaches are in good agreement overall. 
However, one difference is that peak amplitudes of Ca
2+ 
transients elicited by K
+ depolarization differed little   
between WT, R163C Het, and R163C Hom myotubes 
(Estève et al., 2010). In contrast, Ca
2+ transients in re-
sponse to whole cell depolarization were reduced either 
somewhat in R163C Het myotubes or substantially in 
R163C Hom myotubes (Fig. 1), which could be at least 
partially attributed to reduced membrane expression of 
the DHPR (Fig. 2). As far as why this reduced release is 
not seen in the measurements on intact myotubes, one 
possibility is a difference in Ca
2+ buffering. Previous work 
(García and Beam, 1994) has shown that Ca
2+-induced 
Ca
2+ release contributes to depolarization-evoked Ca
2+ 
transients in myotubes when the pipette solution has 
weak Ca
2+ buffering (0.1 mM EGTA), but not when it 
has stronger buffering. Thus, intact R163C Het or Hom 
myotubes may have enhanced Ca
2+-induced Ca
2+ release, 
which can compensate for a reduction in SR Ca
2+ re-
lease that is directly voltage gated.
At least superficially, there also appears to be a dis-
crepancy between the whole cell measurements of L-type 
Ca
2+ current and the small enhancement in extracellu-
lar Ca
2+ entry in R163C Het and Hom myotubes inferred 
from Ca
2+ transients in response to K
+ depolarization 
(Fig. 5 of Estève et al., 2010) because there was actually 
a small reduction in the maximal amplitude of whole 
cell Ca
2+ currents in Het and Hom myotubes (Fig. 3). 
However, it is important to note that the hyperpolariz-
ing shifts in the activation of L-type current in R163C 
Het and Hom myotubes (5 and 7 mV, respectively; 
Table II) mean that the currents in response to weak 
depolarizations were actually larger in the mutant myo-
tubes than in WT (Fig. 3 B). These small hyperpolariz-
ing shifts would likely be of particular importance for 
the response of intact myotubes to 60 mM K
+, which was 
shown  to  produce  depolarizations  to  about  13  mV 
(Table I of Estève et al., 2010), a level that is just barely 
above  threshold  for  eliciting  inward  Ca
2+  current  in 
myotubes bathed in 2 mM Ca
2+ (Fig. 4 of Bannister et 
al., 2009b). A hyperpolarizing shift in activation of skel-
etal L-type channels, which have been shown to be per-
meant to Mn
2+ (Bannister et al., 2009b), may also explain 
the increased Mn
2+ entry observed in R163C Het and 
Hom myotubes in response to K
+ depolarization (Fig. 6 
of Estève et al., 2010).
Importantly, both the whole cell voltage clamp and K
+ 
depolarization experiments demonstrated that the R163C 
mutation causes a hyperpolarizing shift in Ca
2+ release, 
in recordings made at room temperature, hyperpolariz-
ing shifts in the activation of L-type current have also 
been reported for myotubes obtained from Y522S Het 
(5 mV; Durham et al., 2008) and Hom (10 mV; see 
Fig. 6 B of Chelu et al., 2006) mice. A small (3 mV) 
but significant hyperpolarizing shift in activation was 
observed in adult Y522S Het fibers at room temperature 
(Andronache et al., 2009). Although hyperpolarizing 
shifts in the voltage dependence of current activation were 
consistently observed in each of these studies, the effects 
of the MH mutations on the amplitude of L-type currents 
were variable (Fig. 3) (Lamb et al., 1989; Gallant et al., 
1996; Dietze et al., 2000; Chelu et al., 2006; Durham   
et al., 2008; Andronache et al., 2009).
In addition to the shift in the I-V relationship for L-type 
currents of R163C Het and Hom myotubes, we found 
that this MH mutation caused an increased responsive-
ness to the dihydropyridine agonist ±Bay K 8644. In par-
ticular, L-type currents of MHS R163C myotubes were 
potentiated to a greater degree (Hom > Het) than WT 
myotubes (Fig. 4). This observation suggests that one of 
the retrograde effects of R163C mutation on the L-type 
channel activity of the DHPR is to facilitate entry of the 
channel into the long–open gating state (i.e., mode 2; 
Nowycky et al., 1985), which might explain the enhanced 
potentiation by ±Bay K 8644. Interestingly, Bay K 8644 
enhances pharmacologically (halothane or isofluorane) 
induced contractures in both swine and human MHS 
muscle (Williams et al., 1991; Adnet et al., 1992), consis-
tent with the idea that altered L-type current may con-
tribute to the pathogenesis of this disease.
Compared with previous reports on the inactivation 
of L-type current in “normal” human myotubes (Morrill 
et al., 1998; Harasztosi et al., 1999), we found that the in-
activation of L-type current in mouse myotubes occurred 
at substantially more depolarized potentials (Fig. 5). Spe-
cifically, the V1/2inact for WT myotubes was 10–20 mV 
more  depolarized  than  those  previously  reported  by 
Morrill et al. (1998) and Harasztosi et al. (1999). The 
difference between our results and those of these previ-
ous studies may reflect differences in species differences 
(mouse vs. human) and methodology (i.e., voltage pro-
tocol) used to assess inactivation. In adult mouse fibers, 
Andronache et al. (2009) reported that nearly complete 
inactivation (90%) of L-type current in WT fibers oc-
curred after sequential prepulses (30 s each) to 60, 
50, 40, 30, 20, and 10 mV, and complete inactiva-
tion (100%) occurred in Y522S Het fibers. We found 
that L-type currents in WT and R163C Het and Hom 
myotubes were substantially more resistant to inacti-
vation after 30-s prepulses, separated by 60-s epochs   
at 80 mV. Moreover, in contrast to the findings of 
Andronache et al. (2009) on Y522S Het fibers, we observed 
little difference in inactivation between WT and R163C 
Het myotubes. However, an 10-mV hyperpolarizing shift 
in inactivation was observed for R163C Hom myotubes.638 RYR1 influences DHPR function
conformation, of RYR1. Collectively, our present results 
and those presented in the companion paper (Estève   
et al., 2010) support the idea that the altered retro-
grade conformational coupling can affect the function 
which was shown by the whole cell measurements to be 
accompanied by a similar shift in voltage sensor charge 
movements. Fig. 6 presents a qualitative model that can 
account for this shift and some of the other effects of 
the R163C mutation on DHPR gating. The model is 
based on the simple idea that the free energy for activa-
tion of RYR1 upon depolarization, and its deactiva-
tion upon repolarization, is provided by the movement 
of DHPR charged residues (designated “Q” in Fig. 6) 
through the membrane field. If this idea is correct, then 
just as the transition of the DHPR from resting to ECC 
activated would promote the corresponding transition 
of RYR1, alterations of RYR1 that promoted its entry 
into  the  ECC-activated  conformation  would  facilitate 
the corresponding transition of the DHPR. The R163C 
mutation has been shown to cause RYR1 to be activated 
more easily by agonists (Yang et al., 2006), which may in-
dicate that it enters more easily into the ECC-activated 
conformation. If this is the case, it may explain the hy-
perpolarizing  shift  in  the  Q-V  relationship  in  R163C 
Het and Hom myotubes (Fig. 2). It also seems reason-
able that although there is a hyperpolarizing shift in the 
activation of L-type current in R163C Het and Hom 
myotubes (Fig. 3), this shift is less than that for the Q-V 
relationship because the activation of the L-type cur-
rent depends not only on the movement of Q, but also 
on that of an additional charge (“q” in Fig. 6). This ad-
ditional charge is smaller than Q, moves more slowly, 
and moves at potentials that are rightward shifted rela-
tive to those that cause RYR1 to enter the ECC-activated 
state (Dirksen and Beam, 1999). Accordingly, the R163C 
mutation would not have a direct effect on the movement 
of q, and the hyperpolarizing shift in L-type channel acti-
vation would be a “mass-action” consequence of the 
hyperpolarizing shift in the movement of Q and the 
resulting loading of the state of the DHPR just before   
L-type channel opening. If the inactivation of L-type cur-
rent proceeds primarily from the open state of the 
channel, the hyperpolarizing shift in the activation of 
current would be accompanied by a hyperpolarizing shift 
in the voltage dependence of inactivation (Fig. 5 C).
One of the major features observed in the K
+ depolariza-
tion experiments is that the inactivation of ECC during 
prolonged depolarization was slowed in R163C Het and 
Hom myotubes (Figs. 1 and 7 of Estève et al., 2010). Be-
cause the inactivation of ECC leads to a cessation of SR 
Ca
2+ release via RYR1, it seems reasonable to hypothesize 
that cytoplasmic domains of the DHPR, and the foot of 
RYR1, assume a different conformation than in the ECC-
activated state (Fig. 6). If, as hypothesized above, the R163C 
mutation stabilizes the ECC-activated state of the RYR1 
foot domain, it would be expected to slow the rate of entry 
of the DHPR and RYR1 into the ECC-inactivated state.
In conclusion, our work now shows that voltage-driven 
transitions of the skeletal muscle DHPR are affected by 
mutations that alter the function, and presumably the 
Figure 6.  A model that can account for the effects on DHPR gat-
ing, which result from the R163C mutation in RYR1. In the model, 
the major component of DHPR gating charge (Q) moves rapidly 
(milliseconds) upon depolarization and results in a conforma-
tional change of a DHPR cytoplasmic domain(s) from “resting” 
to “ECC activating,” which in turn triggers a corresponding con-
formational change in the cytoplasmic (“foot”) domain of RYR1 
that opens the RYR1 pore (black dotted cylinder). Although the 
movement of Q is necessary for the activation of L-type current via 
the DHPR, it is not sufficient. Opening of the L-type channel pore 
(white dotted cylinder) additionally depends on another DHPR 
charge (q), which moves more slowly (tens of milliseconds), is 
smaller than Q, and moves at more depolarized potentials than 
those causing ECC Ca
2+ release (Dirksen and Beam, 1999). The 
R163C MHS mutation shifts the equilibrium of RYR1 toward the 
open state (Yang et al., 2003, 2006), and if this open state is linked 
to the ECC-activated conformation of the foot domain, it would 
retrogradely  promote  the  ECC-activating  conformation  of  the 
DHPR, with the result that less depolarization would be required 
to move Q (Fig. 2). The hyperpolarizing shift in the movement 
of Q also causes a hyperpolarizing shift in activation of the L-type 
channel (Fig. 3), but this shift is less pronounced because the 
movement of q is not directly affected by the transition of RYR1 to 
the ECC-activated state. During prolonged depolarization (tens 
of seconds), the DHPR shifts to a state that is inactivated for ECC 
(Beam and Horowicz, 2004). Entry into this ECC-inactivated state 
is slowed (Figs. 1 and 7 of Estève et al., 2010) because the ECC-
activated states of RYR1 (and thus the DHPR) are stabilized by the 
R163C MHS mutation.  Bannister et al. 639
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